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The most important applications of Mannich bases are in the field of pharmaceuti-
cal products (1, 2). Studies have revealed that Mannich bases show good anticancer (3),
antimycobacterial (4), remarkable anti-HIV and antitubercular activities (5). The pres-
ence of the basic Mannich side-chain has shown marked antimalarial (6), anti-inflamma-
tory, analgesic (7, 8) and antimicrobial activities (9). Imidazole nucleus is also a major
component of a variety of drugs such as angiotensin II receptor antagonists, oral anti-in-
flammatory agents, protein kinase inhibitors and fungicides (10). It is frequently found
as a part of a large number of biologically and medicinally significant substances (11,
12).
There are not many reports describing the synthesis and biological studies of Mannich
bases bearing imidazole moiety. From this point of view, the present study successfully
describes a general and convenient method for the synthesis of a series of 3-substituted
aminomethyl-5-(2-methyl-4-nitro-1-imidazomethyl)-1,3,4-oxadiazole-2-thiones and depicts
the antimicrobial activity of the newly synthesized Mannich bases.
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Starting from 2-methyl-4-nitro-imidazole, new 5-(2-met-
hyl-4-nitro-1-imidazomethyl)-1,3,4-oxadiazole-2-thione (3)
was synthesized and was subjected to Mannich reaction
with appropriate amines to yield a new series of 3-sub-
stituted aminomethyl-5-(2-methyl-4-nitro-1-imidazo-
methyl)-1,3,4-oxadiazole-2-thiones (4a-j). The structure
of the title compounds was elucidated by elemental
analysis and spectral data. The newly synthesized
Mannich bases were screened for their antibacterial and
antifungal activity. Many of these compounds exhibited
potent antifungal activity.
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EXPERIMENTAL
Melting points were determined in open glass capillaries using a VEEGO, VMP-D
digital melting point apparatus (Veego, India) and are uncorrected. Elemental analyses
were performed on a Perkin-Elmer 2400 analyzer (Perkin-Elmer, USA) and were found
within ± 0.4 % of the theoretical values. The IR spectra were recorded as KBr discs using
a JASCO FTIR 4100 spectrometer (Jasco, Japan). 1H NMR spectra were recorded on a
Bruker Avance II 400 NMR spectrometer (Bruker Instruments Inc., USA) using CDCl3 or
DMSO-d6 as solvent and TMS as internal standard. Mass spectra were measured on a
JEOL GCMATE II mass spectrometer (Jeol, Japan).
2-Methyl-4-nitro imidazole, ethyl choloroacetate, ciprofloxacin and fluconazole
were procured from Sigma-Aldrich, USA. All other chemicals used in the study were of
analytical grade.
Synthetic procedures
2-Methyl-4-nitro-1-imidazo-ethyl acetate (1). – A mixture of 2-methyl-4-nitro-imidazole
(12.7 g, 0.1 mol), ethyl chloroacetate (10.7 mL, 0.1 mol) and potassium carbonate (20.4 g,
0.15 mol) in dry acetone (200 mL) was refluxed for 50 h. The reaction mixture was fil-
tered hot and the solvent was distilled off from the filtrate. The crude ester 1 thus ob-
tained was purified by recrystallization from absolute ethanol.
2-Methyl-4-nitro-1-imidazo-acethydrazide (2). – A mixture of ester (1) (21.3 g, 0.1 mol)
and 99 % hydrazine hydrate (4.9 mL, 0.1 mol) in absolute ethanol (50 mL) was refluxed
for 8 h. On cooling, the solution gave a solid mass of hydrazide 2, which was collected
by filtration, and recrystallized from absolute ethanol.
5-(2-Methyl-4-nitro-1-imidazomethyl)-1,3,4-oxadiazole-2-thione (3). – A mixture of 2-meth-
yl-4-nitro-1-imidazo-acethydrazide (2) (19.9 g, 0.1 mol), KOH (5.6 g, 0.1 mol), carbon
disulphide (6.0 mL, 0.1 mol) in absolute ethanol (100 mL) was placed in a
round-bottomed flask fitted with a water cooled condenser and refluxed on a water bath
till the evolution of hydrogen sulphide ceased. The excess of alcohol was removed by
distillation. The reaction mixture was cooled to room temperature and the contents were
poured to ice-cold water and neutralized with dilute hydrochloric acid. The solid
precipitated was filtered, washed thoroughly with water and dried. The product was
further purified by recrystallization from the ethanol-dioxane mixture (1:1) to give 3.
3-Substituted aminomethyl-5-(2-methyl-4-nitro-1-imidazomethyl)-1,3,4-oxadiazole-2-thiones
(4a–j). – A mixture of the solution of 5-(2-methyl-4-nitro-1-imidazomethyl)-1,3,4-oxadia-
zole-2-thione (3) (2.41 g, 0.01 mol) in absolute ethanol and dioxane mixture (1:1, 20 mL)
was treated with formaldehyde (40 %, 1.5 mL, 0.05 mol). Later, the appropriate amine
(0.01 mol) in absolute ethanol (10 mL) was added with stirring and the reaction mixture
was stirred overnight. The precipitated Mannich base was collected by filtration and dried.
Recrystallization was done from the ethanol-DMF mixture (1:1) to give compounds 4a–j.
Antimicrobial studies
The antimicrobial activity of the newly synthesized Mannich bases was checked
against three fungal strains, viz., Candida albicans, Trichophyton rubrum and Trichophyton
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mentagrophytes and two pathogenic bacteria, viz., Staphylococcus aureus and Streptococcus
pyogenes. Fluconazole and ciprofloxacin were used as standards. The synthesized com-
pounds and standards were dissolved in DMSO to give a concentration of 1000 µg mL–1.
The minimum inhibitory concentration (MIC) was determined by the two-fold tube di-
lution method (13). Dilutions of test and standard compounds were prepared in
Sabouraud dextrose broth for fungi and nutrient broth for bacteria. The samples were
incubated at 25 °C for 48 hours for C. albicans, 5–7 days at 20–22 °C for T. rubrum and T.
mentagrophytes and at 37 °C for 24 hours for bacteria. At the end of the incubation pe-
riod, MIC values were recorded as the lowest concentrations of substances that showed
no visible turbidity.
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In the present work, a series of Mannich bases has been synthesized. Elimination
reaction of 2-methyl-4-nitro-1H-imidazole with ethyl chloroacetate in the presence of po-
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tassium carbonate and dry acetone led to the formation of ethyl (2-methyl-4-nitro-1H-
imidazol-1-yl) acetate (1). The resulting ester was subjected to hydrazinolysis to yield a
solid mass of 1-[2-(hydrazinooxy)-2-oxoethyl]-2-methyl-4-nitro-1H-imidazole (2), which
when refluxed with KOH and carbon disulphide in ethanol gave new 5-[(2-methyl-
-4-nitro-1H-imidazol-1-yl)methyl]-1,3,4-oxadiazole-2(3H)-thione (3). New Mannich bases
(4a-j) were obtained by the reaction of 1,3,4-oxadiazole with appropriate amines in the
presence of 40 % formaldehyde (Scheme 1) in moderate to good yields.
The newly synthesized compounds were characterized by spectral data and ele-
mental analysis. In the IR spectra of compounds 4a-j, the absorption band due to the
thione (C=S) group was observed at 1100–1150 cm–1. In the 1H NMR spectra of these
Mannich bases, the signal due to thione proton around d 13–15 ppm was absent, indi-
cating the formation of a Mannich base. In a typical example, the 1H NMR spectrum of
4d showed a sharp singlet at d 2.26 ppm integrating for three protons of the methyl group
of imidazole moiety. The -N-CH2-N- protons appeared at d 5.66 ppm as a singlet inte-
grating for two protons, while the CH2 protons connecting the oxadiazole and imidazole
moiety appeared as a singlet at d 5.21 ppm integrating for two protons. The ortho- and
meta-protons of p-chlorophenyl moiety appeared as two doublets centered at d 7.38 and
7.67 ppm, each integrating for two protons. The imidazole 5-H proton appeared as a sing-
let at d 8.09 ppm integrating for one proton. The signal due to the NH proton appeared
as a broad singlet at d 10.13 ppm integrating for one proton.
Further evidence for the proposed structure of Mannich bases was obtained by
recording their mass spectra. In most cases, the molecular ion peaks were very weak
indicating that the molecular ions were not stable (Scheme 2). The fragmented peaks
observed in these cases are in conformity with their respective assigned structures. The
fragmentation paths for these compounds are shown in Scheme 2. Elemental analysis
data together with IR, 1H NMR and MS data supported the proposed structures for
compounds 1-3 and 4a-j (Tables I and II).
Structure and antimicrobial activity
Newly synthesized 3-substituted aminomethyl-5-(2-methyl-4-nitro-1-imidazometh-
yl)-1,3,4-oxadiazole-2-thiones (4a-j) were examined for antimicrobial activity and the
reults are summarized in Table III. The antifungal screening results revealed that Man-
nich base 4b-j exhibited higher to moderate activity against C. albicans and T. mentagro-
phytes compared to standard fluconazole. Compound 4a with phenyl substituent show-
ed the least activity.
All aminomethyl-5-(2-methyl-4-nitro-1-imidazomethyl)-1,3,4-oxadiazole-2-thiones pos-
sessing different substituent groups (4b-j), except 4a, showed higher inhibitory activity
against C. albicans than the reference fluconazole. It is worth noting that compound 4c
with p-fluorophenyl substituent and 4f with 2-methyl-4-nitrophenyl substituent showed
5-fold better in vitro activity against C. albicans with MIC 172 and 154 µmol L–1,
respectively, compared to the standard drug fluconazole (MIC 816 µmol L–1). Besides,
compound 4h (MIC 368 µmol L–1) integrating piperazinyl group exhibited 2-fold better
activity than the standard drug fluconazole.
Furthermore, the compounds with ethyl, fluoro and bromo groups at para position
in phenyl substituent (4b, 4c and 4e), with 2-methyl-4-nirophenyl substituent (4f), and
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2980 (CH), 1728 (C=O),
1533 (N=C)
1.28 (t, 3H, CH3), 2.34 (s, 3H, CH3), 4.22 (q, 2H,




3151 (NH), 2962 (CH),
1686 (C=O), 1598 (N=C)
2.33 (s, 3H, CH3), 4.71 (s, 2H, N-CH2), 5.08 (s, 2H,




3142 (NH), 2952 (CH),
1620 (N=C), 1135 (C=S)
2.40 (s, 3H, CH3), 5.38 (s, 2H, N-CH2), 8.16 (s, 1H,





1595 (N=C), 1133 (C=S)
2.34 (s, 3H, CH3), 5.09 (s, 2H, N-CH2), 5.61 (s, 2H,
N-CH2-N), 7.25 (t, 1H, ArH), 7.38 (t, 2H, ArH),
7.60 (d, 2H, ArH), 8.04 (s, 1H, H-5 imidazole),
10.23 (s, 1H, NH)
346 (M+H)+
4b
3133 (N-H), 2959 (C-H),
1542 (N=C), 1139 (C=S)
2.33 (s, 3H, CH3), 2.51 (q, 2H, CH2), 2.63 (t, 3H,
CH3), 5.27 (s, 2H, N-CH2), 5.63 (s, 2H, N-CH2-N),
7.32 (d, 2H, ArH), 7.60 (d, 2H, ArH), 8.25 (s, 1H,
H-5 imidazole), 10.13 (s, 1H, NH)
374 (M+H)+
4c
3150 (N-H), 2946 (C-H),
1551 (N=C), 1133 (C=S)
2.33 (s, 3H, CH3), 5.11 (s, 2H, N-CH2), 5.66 (s, 2H,
N-CH2-N), 7.15 (t, 2H, ArH),7.65 (d, 2H, ArH),
8.11 (s, 1H, H-5 imidazole), 10.78 (s, 1H, NH)
365 (M+H)+
4d
3152 (N-H), 3049 (C-H),
1539 (N=C), 1131 (C=S)
2.26 (s, 3H, CH3), 5.21 (s, 2H, N-CH2), 5.66 (s, 2H,
N-CH2-N), 7.38 (d, 2H, ArH), 7.71 (d, 2H, ArH),
8.09 (s, 1H, H-5 imidazole), 10.13 (s, 1H, NH)
381 (M+H)+
4e
3132 (N-H), 2956 (C-H),
1543 (N=C), 1140 (C=S)
2.33 (s, 3H, CH3), 5.26 (s, 2H,N-CH2), 5.67 (s, 2H,
N-CH2-N), 7.38 (d, 2H, ArH), 7.71 (d, 2H, ArH),
8.23 (s, 1H, H-5 imidazole), 10.21 (s, 1H, NH)
425 (M+H)+
4f
3121 (N-H), 3076 (C-H),
1534 (N=C), 1147 (C=S)
2.20 (s, 3H, CH3), 2.34 (s, 3H, CH3), 5.49 (s, 2H,
N-CH2), 5.52 (s, 2H, N-CH2-N), 7.03 (s, 1H, ArH),
7.48 (s, 1H, ArH),7.96 (s, 1H, ArH), 8.37 (s, 1H,
H-5 imidazole), 10.24 (s, 1H, NH)
405 (M+H)+
4g
2940 (C-H), 1593 (N=C),
1107 (C=S)
2.36 (s, 3H, CH3), 5.18 (s, 2H, N-CH2), 5.84 (s, 2H,




2939 (C-H), 1596 (N=C),
1112 (C=S)
2.46 (s, 3H, CH3), 2.55 (t, 4H, CH2-piperazine),
3.26 (t, 4H, CH2-piperazine), 4.97 (s, 2H, N-CH2),
5.53 (s, 2H, N-CH2-N), 8.09 (s, 1H, H-5
imidazole), 8.34 (s, 1H, NH-piperazine)
339 (M+H)+
4i
2935 (C-H), 1595 (N=C),
1102 (C=S)
1.36 (s, 3H, CH3), 5.03 (s, 3H, NCH3), 2.42 (m,
4H, CH2 -piperazine), 2.75 (m, 4H, CH2 –
piperazine), 4.97 (s, 2H, N-CH2), 5.53 (s, 2H,





1.37 (s, 3H, CH3), 4.90 (q, 2H, piperazine-N-CH2),
1.20 (t, 3H, piperazine-CH3), 2.41 (m, 4H, CH2
-piperazine), 2.77 (m, 4H, CH2 – piperazine), 4.95
(s, 2H, N-CH2), 5.53 (s, 2H, N-CH2-N), 8.18 (s,
1H, H-5 imidazole)
368 (M+H)+
with methyl piperazinyl (4i) or ethyl piperazinyl unit (4j), showed higher activity
against T. mentagrophytes (MIC values ranging between 86–340 µmol L–1) compared to
fluconazole (MIC 408 µmol L–1). Among these, compound 4c exhibited about 5-times
better antifungal activity with MIC value 86 µmol L–1. Nevertheless, all the tested
compounds exhibited weaker activity than fluconazole against T. rubrum. In case of
antibacterial activity, almost all the compounds showed weaker activity than
237
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Scheme 2.
ciprofloxacin against S. pyogenes and S. aureus. However, piperazinyl substituted
compound 4h with MIC value 184 µmol L-1 showed promising activity against S. aureus
compared to the standard antibiotic ciprofloxacin (MIC 189 µmol L-1).
CONCLUSIONS
A series of new 3-substituted aminomethyl-5-(2-methyl-4-nitro-1-imidazometh-
yl)-1,3,4-oxadiazole-2-thiones (4a-j) have been synthesized and tested for their antifun-
gal and antimicrobial activities. The results revealed that most of the compounds exhi-
bited moderate to good activity against C. albicans, T. mentagrophytes and S. aureus. Com-
pounds 4b-j exhibited excellent antifungal activity against C. albicans with low MIC va-
lues. In addition, compound 4c with fluoro substitution exhibited about 5-fold enhanced
activity against T. mentagrophytes compared to fluconazole. The antifungal strength of cer-
tain tested compounds was more pronounced than their antibacterial activities. Thus,
the promising activities and easy synthesis of Mannich bases carrying imidazole moiety
make them very attractive antifungal leads. Further, a complete structure activity rela-
tionship and mechanistic approach could contribute to the development of new antimi-
crobial drugs.
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Table III. Antimicrobial activity of synthesized Mannich bases
Compd.
MIC (µmol L–1)
Antifungal activity Antibacterial activity
C. albicans T. rubrum T. mentagrophytes S. pyogenes S. aureus
4a 1443 1443 1443 2887 1443
4b 668 334 334 1335 334
4c 172 343 86 686 343
4d 657 657 1313 657 1313
4e 588 294 294 1175 294
4f 154 308 308 308 308
4g 592 1184 1184 592 1184
4h 368 737 737 368 184
4i 707 354 354 354 354
4j 680 340 340 340 340
Ciprofloxacin – – – 94 189
Fluconazole 816 200 408 – –
Solvent control
(DMSO)
– – – – –
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